Receptor tyrosine kinases and targeted cancer therapeutics.
about
Fibroblasts, an inconspicuous but essential player in colon cancer development and progressionDynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalkAeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine DrugTargeting RTK Signaling Pathways in CancerProfiling invasiveness in head and neck cancer: recent contributions of genomic and transcriptomic approachesOTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic KinasesInsulin-like growth factor system in cancer: novel targeted therapiesFGF receptors: cancer biology and therapeuticsDisrupting the networks of cancerThe design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agentsMET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated DegradationComputational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy.Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signatureDetection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS)The Function of V-ATPases in CancerInterrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Anti-cancer Therapies in High Grade Gliomas.Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer.Combined KIT and FGFR2b signaling regulates epithelial progenitor expansion during organogenesis.Septins: Regulators of Protein Stability.Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexesTargeting angiogenesis for the treatment of prostate cancer.Molecular mechanisms of lung-specific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors.The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.Signal transduction in podocytes--spotlight on receptor tyrosine kinases.Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy.Priming cancer cells for drug resistance: role of the fibroblast niche.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib.Functional protein micropatterning for drug design and discovery.Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.GDNF induces RET-SRC-HER2-dependent growth in trastuzumab-sensitive but SRC-independent growth in resistant breast tumor cells.Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis.Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell.Synthesis and evaluation of biological and antitumor activities of 5,7-dimethyl- oxazolo[5,4-d]pyrimidine-4,6(5H,7H)-dione derivatives as novel inhibitors of FGFR1.Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling.
P2860
Q26747341-98D4CFFC-E104-4264-806A-8F8E3930AE74Q26765201-D769490F-7022-4291-8791-9223743F8253Q26772014-D9180DFC-E2C7-4DD6-9EC3-4D9C779C5A13Q26781278-DF79E82E-4D06-45E7-81D7-3B2EFA0D5DADQ26995360-98CA1F6A-6175-4677-A249-8257A3AE2F6BQ27313731-D412C1A4-8275-48C7-ADEC-B3BB62D79FD7Q28081603-FA782DB8-39A8-4F3A-83B6-D994E6DB0E03Q28291186-836F3B80-3E8D-4BF2-83C9-E51D73A008E6Q28656016-E7D636CE-C84D-4193-AE39-2552F541374AQ33872751-56BFF21C-8E5D-41A1-A48D-A06F030CCCC0Q35800730-D0A26D0B-D9ED-43B8-B183-CAD615E3552EQ35993392-8BB8F4F4-E8B3-45A2-B11E-5A3E31BF757AQ36111593-E3B07B32-7313-4EF5-8FCF-C6413FDC27A1Q36210809-E641670E-963F-4EA5-85B3-45278FC16A7AQ36342992-7CCF9882-D9D4-4F71-8D0E-20637043BBDEQ37169505-90BE94E8-2381-4A00-AA79-C1A150B65E9CQ37236103-B7A5B77B-F897-4585-9A40-B5DB0C2E4583Q37290626-F9D3CD20-8641-4E8D-AF0C-18A7E9D70687Q37397413-0520915E-18BA-481E-AF95-3F588CFE3792Q37410920-5E974850-178A-4B4F-A07A-B4784974F298Q37516409-7A1E1A3D-4B0D-4D3F-A60D-2C3FDCF7E548Q37578752-7AACFE44-ACE9-4094-945C-9336F526C1CBQ37993137-B7B466FD-B428-428B-9DDD-D00BCCF47832Q38060727-965D3E84-8F30-4DC4-96BC-34A249F96BC6Q38097400-96DB9DA8-E2E1-409D-815A-3AA75908A679Q38176169-93667783-A1C1-4511-9410-3E2372FA8C7EQ38208280-EECDE626-0E67-4CBD-9004-0122A7D139EBQ38232067-1996B4B1-9A5C-4898-9053-FA984F8D019DQ38233171-1F0B9C6C-AA2F-4657-9239-DBF73D235975Q38632417-06D22B39-5A9F-4FEA-9DE7-85A3F87F8245Q38654896-F4BE6A83-62F0-4F82-B0EE-771A5EC05B85Q38708092-95CD5A62-9C5A-48C3-A031-80F7FFCB4D10Q38719786-84777D30-97E6-43D2-9414-E47CFE421F79Q38740434-68ACC02D-D5B0-43B9-A000-FFCD363E1925Q38780786-8FDD280B-5CDD-4362-B24E-B668B0019D4FQ38830422-76788D09-6C96-43C1-A401-D3E6F7B92BE9Q38830819-77E4E97C-5A06-4EF7-8520-E3A7653113A6Q38909492-72FBE4C8-9830-4E17-80A7-DAF5C3C08D6FQ39218100-8F038FC5-AF0F-4277-B769-78E792483756Q40463360-2188D0D3-4318-4CBC-B968-774A6DD81E48
P2860
Receptor tyrosine kinases and targeted cancer therapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Receptor tyrosine kinases and targeted cancer therapeutics.
@en
Receptor tyrosine kinases and targeted cancer therapeutics.
@nl
type
label
Receptor tyrosine kinases and targeted cancer therapeutics.
@en
Receptor tyrosine kinases and targeted cancer therapeutics.
@nl
prefLabel
Receptor tyrosine kinases and targeted cancer therapeutics.
@en
Receptor tyrosine kinases and targeted cancer therapeutics.
@nl
P356
P1476
Receptor tyrosine kinases and targeted cancer therapeutics.
@en
P2093
Fumiaki Ito
Kenji Takeuchi
P304
P356
10.1248/BPB.34.1774
P577
2011-01-01T00:00:00Z